 |
 |
 |
 | Stabilization of vaccines/biologics
FibroGen has synthesized FG-5009, a gelatin molecule optimized for
use in vaccine and biologic formulations. Working with leaders in
the vaccine market, FibroGen has tested the ability of FG-5009 to
stabilize several live attenuated viral vaccines. In vitro
stabilization studies have demonstrated that FG-5009 is equivalent
to the animal-derived gelatin stabilizer in commercially available
vaccines. FibroGen is currently working with customers on formulation
development and testing FG-5009 as a stabilizer for other
biopharmaceuticals and as an alternative to human serum albumin.
|
|
|
|
